Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.

Lai ZW, Borsuk R, Shadakshari A, Yu J, Dawood M, Garcia R, Francis L, Tily H, Bartos A, Faraone SV, Phillips P, Perl A.

J Immunol. 2013 Sep 1;191(5):2236-46. doi: 10.4049/jimmunol.1301005. Epub 2013 Aug 2.

2.

Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.

Garcia RJ, Francis L, Dawood M, Lai ZW, Faraone SV, Perl A.

Arthritis Rheum. 2013 May;65(5):1313-8. doi: 10.1002/art.37893.

3.

Intraoperative neuromonitoring in pediatric surgery.

Francis L, Mohamed M, Patino M, McAuliffe J.

Int Anesthesiol Clin. 2012 Fall;50(4):130-43. doi: 10.1097/AIA.0b013e31826f32ae. No abstract available.

PMID:
23047452
4.

Obstructive sleep apnea syndrome: anesthetic concerns.

Patino M, McAuliffe J, Francis L, Mohamed M.

Int Anesthesiol Clin. 2012 Fall;50(4):41-53. doi: 10.1097/AIA.0b013e31826e32af. Review. No abstract available.

PMID:
23047445
5.

N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.

Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, Miklossy G, Jimah J, Doherty E, Tily H, Francis L, Garcia R, Dawood M, Yu J, Ramos I, Coman I, Faraone SV, Phillips PE, Perl A.

Arthritis Rheum. 2012 Sep;64(9):2937-46. doi: 10.1002/art.34502.

6.

Infection in systemic lupus erythematosus: friend or foe?

Francis L, Perl A.

Int J Clin Rheumtol. 2010 Feb 1;5(1):59-74.

7.

Induction of systemic lupus erythematosus with tumor necrosis factor blockers.

Soforo E, Baumgartner M, Francis L, Allam F, Phillips PE, Perl A.

J Rheumatol. 2010 Jan;37(1):204-5. doi: 10.3899/jrheum.081312. No abstract available.

PMID:
20040644
8.

T-cell and B-cell signaling biomarkers and treatment targets in lupus.

Perl A, Fernandez DR, Telarico T, Doherty E, Francis L, Phillips PE.

Curr Opin Rheumatol. 2009 Sep;21(5):454-64. doi: 10.1097/BOR.0b013e32832e977c. Review.

9.

Pharmacotherapy of systemic lupus erythematosus.

Francis L, Perl A.

Expert Opin Pharmacother. 2009 Jun;10(9):1481-94. doi: 10.1517/14656560902971003. Review.

PMID:
19505215
10.

Hypertrophic osteoarthropathy masquerading as lower extremity cellulitis and response to bisphosphonates.

Mauricio O, Francis L, Athar U, Shah C, Chaudhary M, Gajra A.

J Thorac Oncol. 2009 Feb;4(2):260-2. doi: 10.1097/JTO.0b013e3181952915.

PMID:
19179906
11.

Obesity: effects on cardiovascular disease and its diagnosis.

Mathew B, Francis L, Kayalar A, Cone J.

J Am Board Fam Med. 2008 Nov-Dec;21(6):562-8. doi: 10.3122/jabfm.2008.06.080080. Review.

12.

Coronary artery aneurysm related to percutaneous coronary intervention.

Mathew B, Francis L.

Int J Cardiol. 2009 Sep 11;137(1):e5-7. doi: 10.1016/j.ijcard.2008.05.065. Epub 2008 Aug 3.

PMID:
18676039
13.

Clinical policy: critical issues in the sedation of pediatric patients in the emergency department.

Mace SE, Brown LA, Francis L, Godwin SA, Hahn SA, Howard PK, Kennedy RM, Mooney DP, Sacchetti AD, Wears RL, Clark RM; EMSC Panel on Critical Issues in the Sedation of Pediatric Patients in the Emergency Department.

J Emerg Nurs. 2008 Jun;34(3):e33-107. doi: 10.1016/j.jen.2008.04.018. No abstract available.

PMID:
18558240
14.

Clinical policy: Critical issues in the sedation of pediatric patients in the emergency department.

Mace SE, Brown LA, Francis L, Godwin SA, Hahn SA, Howard PK, Kennedy RM, Mooney DP, Sacchetti AD, Wears RL, Clark RM; EMSC Panel (Writing Committee) on Critical Issues in the Sedation of Pediatric Patients in the Emergency.

Ann Emerg Med. 2008 Apr;51(4):378-99, 399.e1-57. doi: 10.1016/j.annemergmed.2007.11.001. Review. No abstract available.

PMID:
18359378
15.

Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin.

Francis L, Bonilla E, Soforo E, Neupane H, Nakhla H, Fuller C, Perl A.

Clin Rheumatol. 2008 Jan;27(1):129-31. Epub 2007 Jul 13.

PMID:
17628739
16.

Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients.

Bonilla E, Francis L, Allam F, Ogrinc M, Neupane H, Phillips PE, Perl A.

Clin Immunol. 2007 Jul;124(1):18-21. Epub 2007 May 21.

17.

Nonsurgical carotid revascularization.

Mathew B, Bhatia V, Francis L.

Cardiol Rev. 2005 Jul-Aug;13(4):197-9. Review.

PMID:
15949054
18.

Elevation of the tumor marker CA125 in right heart failure.

Mathew B, Bhatia V, Mahy IR, Ahmed I, Francis L.

South Med J. 2004 Oct;97(10):1013-4.

PMID:
15558934
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk